Dupilumab associated with significantly lower malignancy risks in atopic dermatitis

Press/Media

Period	20 Dec 2024

Media coverage

Title	Dupilumab associated with significantly lower malignancy risks in atopic dermatitis
Media name/outlet	Healio
Country/Territory	United States
Date	20/12/24
URL	https://www.healio.com/news/allergy-asthma/20241220/dupilumab-associated-with-significantly-lower-malignancy-risks-in-atopic-dermatitis
Persons	Nicholas Gulati